Skip to main content

AZN Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

AstraZeneca PLC News

Alnylam's 5th Drug Launches in July, Disrupting Commercial Landscape

A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.

Roche Shows Interest in This Small-Cap Biotech. Should You?

An emerging therapeutic area continues to draw interest from large drugmakers.

Cramer's Mad Money Recap 4/20: Netflix, Disney, Tesla

What works? Jim Cramer says to invest in companies that make things, at a profit, and return some of those profits to shareholders while maintaining a reasonable share price for its growth rate.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

Amazon, GameStop, Jefferies, Covid Concerns and Stock Markets - Five Things You Must Know

Stock futures slip lower as Covid worries and inflation concerns come into focus; AstraZeneca gets FDA nod for its antibody treatment; Jefferies sends bankers home after NY Covid outbreak; Amazon hit with record $1.3 billion fine in Italy and GameStop unveils a wider third quarter loss and details of a new SEC subpoena.

Breaking News

Ford Makes a Major Change

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.